Publications

Comparative Effectiveness of Tocilizumab as Monotherapy Versus Tnf Inhibitors in Combination with Conventional Synthetic Disease Modifying Antirheumatic Drugs in Bionaive Patients with Rheumatoid Arthritis

AuthID
P-00P-PJ9

Author(s)

Lauper, K

Kvien, TK

Codreanu, C

Hernandez, MV

Ianonne, F

Kristianslund, EK

Lukina, G

Nordstrom, DC

Pavelka, K

Rotar, Z

Santos, MJ

Gale, SL

John, M

Luder, Y

Courvoisier, DS

Gabay, C

Group Author(s)

Rheuma Pt

Document Type

Abstract

Year published

2018

Published

in ANNALS OF THE RHEUMATIC DISEASES, ISSN: 0003-4967

Volume: 77, Pages: 320-321 (2)

Conference

Congress of the European-League-Against-Rheumatism (Eular), Date: JUN 13-16, 2018, Location: Amsterdam, NETHERLANDS, Sponsors: European League Against Rheumatism

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1136/annrheumdis-2018-eular.1606

Wos: WOS:000444351001010

Source Identifiers

ISSN: 0003-4967

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Comparative Effectiveness of Tocilizumab as Monotherapy Versus Tnf Inhibitors in Combination with Conventional Synthetic Disease Modifying Antirheumatic Drugs in Bionaive Patients with Rheumatoid Arthritis

Useful Links

Get Help

Federated Authentication (Click on the image)

Comparative Effectiveness of Tocilizumab as Monotherapy Versus Tnf Inhibitors in Combination with Conventional Synthetic Disease Modifying Antirheumatic Drugs in Bionaive Patients with Rheumatoid Arthritis

Useful Links

Get Help